Neoplasm

Neoplasm

Self-Propelling Nanobots Reduce Bladder Tumor Size by 90% in Mice Study showed how tiny nanomachines, propelled by urea present in urine, precisely target the tumour and attack it with a radioisotope carried on their surface.

A groundbreaking study has revealed an innovative approach to treating neoplasms, specifically bladder tumors. Researchers have successfully demonstrated the effectiveness of self-propelling nanobots in reducing tumor size by an astounding 90% in a mice study. These nanomachines, powered by the urea present in urine, exhibit remarkable precision in targeting the tumor and attacking it with a radioisotope carried on their surface.

The implications of this study are immense, offering new hope for the treatment of neoplasms in humans. By harnessing the power of nanotechnology, scientists have unlocked a potential solution that could revolutionize cancer therapy. The ability of these nanobots to specifically target tumors and deliver targeted radiation therapy holds great promise for improving patient outcomes and minimizing the side effects associated with traditional treatments.